Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients

Electron microscopy and immunoperoxidase studies of early multiple sclerosis lesions

Prineas, J. W., & Raine, C. S. (1976) · Neurology · doi:10.1212/wnl.26.6_part_2.29 · Cited by 113 · see citing works

Binding of normal human IgG to myelin sheaths, glia and neurons.

Aarli, J. A., Aparicio, S. R., LUMSDEN, C. E., & Tönder, O. (1975) · PubMed Central · Cited by 108 · see citing works

EVIDENCE FOR IMMUNE-COMPLEX FORMATION IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS

Oldstone, M. B. A., Perrin, L. H., Wilson, C. B., & Norris, F. H. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92345-x · Cited by 65 · see citing works

Oligodendrocyte staining by multiple sclerosis serum is nonspecific

Traugott, U., Snyder, D. S., & Raine, C. S. (1979) · Annals of Neurology · doi:10.1002/ana.410060104 · Cited by 63 · see citing works

ACETYLCHOLINE-RECEPTOR ANTIBODIES IN CEREBROSPINAL FLUID OF PATIENTS WITH MYASTHENIA GRAVIS

Lefvert, A. K., & Pirskanen, R. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91506-9 · Cited by 57 · see citing works

Amyotrophic Lateral Sclerosis: Recent Research Trends

Mulder, D. W. (1977) · JAMA · doi:10.1001/jama.1977.03270500094044 · Cited by 44 · see citing works

Immunological profile of amyotrophic lateral sclerosis patients and their cell-mediated immune responses to viral and CNS antigens.

Bartfeld, H., Dham, C., Donnenfeld, H., Jashnani, L., Carp, R., Kascsak, R., Vilček, J., Rapport, M. M., & Wallenstein, S. R. (1982) · PubMed Central · Cited by 42 · see citing works

Potential pathogenic mechanisms of injury in amyotrophic lateral sclerosis.

Oldstone, M. B. A., Lh, P., & Rm, W. (1976) · PubMed · Cited by 3 · see citing works

Blood-Brain Barrier: From Physiology to Disease and Back

Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works

The blood–brain barrier in health and disease

Daneman, R. (2012) · Annals of Neurology · doi:10.1002/ana.23648 · Cited by 756 · see citing works

Brain metabolism in health, aging, and neurodegeneration

Camandola, S., & Mattson, M. P. (2017) · The EMBO Journal · doi:10.15252/embj.201695810 · Cited by 752 · see citing works

The blood–spinal cord barrier: Morphology and Clinical Implications

Bartanusz, V., Ježová, D., Alajajian, B., & Digicaylioglu, M. H. (2011) · Annals of Neurology · doi:10.1002/ana.22421 · Cited by 479 · see citing works

Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis

Winkler, E. A., Sengillo, J. D., Sullivan, J. S., Henkel, J. S., Appel, S. H., & Zlokovic, B. V. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1039-8 · Cited by 354 · see citing works

Inflammation in ALS/FTD pathogenesis

McCauley, M. E., & Baloh, R. H. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1933-9 · Cited by 316 · see citing works

Barrier function in the peripheral and central nervous system—a review

Reinhold, A., & Rittner, H. L. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1920-8 · Cited by 279 · see citing works

Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALS

Garbuzova-Davis, S. N., Saporta, S., Haller, E. M., Kolomey, I., Bennett, S. P., Potter, H., & Sanberg, P. R. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001205 · Cited by 248 · see citing works

Ultrastructure of blood–brain barrier and blood–spinal cord barrier in SOD1 mice modeling ALS

Garbuzova-Davis, S., Haller, E., Saporta, S., Kolomey, I., Nicosia, S. V., & Sanberg, P. R. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.044 · Cited by 239 · see citing works

The Role of Immune and Inflammatory Mechanisms in ALS

McCombe, P., & Henderson, R. D. (2011) · Current Molecular Medicine · doi:10.2174/156652411795243450 · Cited by 234 · see citing works

IgG Reactivity in the Spinal Cord and Motor Cortex in Amyotrophic Lateral Sclerosis

Engelhardt, J. I., & Appel, S. H. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530110068019 · Cited by 221 · see citing works

Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System

Carpanini, S. M., Torvell, M., & Morgan, B. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00362 · Cited by 207 · see citing works

Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases

Brkic, M., Balusu, S., Libert, C., & Vandenbroucke, R. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/620581 · Cited by 205 · see citing works

Inflammation and neurovascular changes in amyotrophic lateral sclerosis

Evans, M. C., Couch, Y., Sibson, N. R., & Turner, M. R. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.008 · Cited by 174 · see citing works

Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia

Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175 · see citing works

Impaired blood–brain and blood–spinal cord barriers in mutant SOD1-linked ALS rat

Nicaise, C., Mitrecic, D., Demetter, P., De Decker, R., Authelet, M., Boom, A., & Pochet, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.018 · Cited by 168 · see citing works

Motor Neuron Disease (Amyotrophic Lateral Sclerosis)

WILLIAMS, D. B., & Windebank, A. J. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61175-6 · Cited by 153 · see citing works

Single-cell dissection of the human motor and prefrontal cortices in ALS and FTLD

Pineda, S. S., Lee, H., Fitzwalter, B. E., Mohammadi, S., Pregent, L., Gardashli, M., Mantero, J. C., Engelberg-Cook, E., DeJesus‐Hernandez, M., van Blitterswijk, M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.02.031 · Cited by 150 · see citing works

Blood-CNS Barrier Impairment in ALS patients versus an animal model

Garbuzova-Davis, S. N., & Sanberg, P. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00021 · Cited by 146 · see citing works

Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons

Lobsiger, C. S., Boillée, S., & Cleveland, D. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702230104 · Cited by 139 · see citing works

Amyotrophic lateral sclerosis: A neurovascular disease

Garbuzova-Davis, S. N., Rodrigues, M. C. O., Hernandez‐Ontiveros, D. G., Louis, M. K., Willing, A. E., Borlongan, C. V., & Sanberg, P. R. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.049 · Cited by 128 · see citing works

LRP 4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients

Tzartos, J. S., Zisimopoulou, P., Rentzos, M., Karandreas, N., Zouvelou, V., Evangelakou, P., Tsonis, A., Thomaides, T., Lauria, G., Andreetta, F., et al. (2013) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.26 · Cited by 115 · see citing works

Serum and CSF immunological findings in ALS

Apostolski, S., Nikolić, J., Bugarski-Prokopljević, C., Miletić, V., Pavlović, S., & Filipović, S. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb04656.x · Cited by 114 · see citing works

New tricks for an ancient system: Physiological and pathological roles of complement in the CNS

Tenner, A. J., Stevens, B., & Woodruff, T. M. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.264 · Cited by 112 · see citing works

Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration

Wilkins, H. M., Weidling, I. W., Ji, Y., & Swerdlow, R. H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00508 · Cited by 102 · see citing works

Non‐neuronal Cells in ALS: Role of Glial, Immune cells and Blood‐CNS Barriers

Puentes, F., Malaspina, A., van Noort, J. M., & Amor, S. (2016) · Brain Pathology · doi:10.1111/bpa.12352 · Cited by 98 · see citing works

Amyotrophic Lateral Sclerosis

Mitsumoto, H. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520260077025 · Cited by 98 · see citing works

TNF and sTNFR1/2 plasma levels in ALS patients

Cereda, C., Baiocchi, C., Bongioanni, P., Cova, E., Guareschi, S., Metelli, M. R., Rossi, B., Sbalsi, I., Cuccia, M. C., & Ceroni, M. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.10.028 · Cited by 94 · see citing works

Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood

Mantovani, S., Gordon, R., Macmaw, J. K., Pfluger, C. M., Henderson, R. D., Noakes, P. G., McCombe, P., & Woodruff, T. M. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.09.005 · Cited by 78 · see citing works

Complement in the Pathophysiology and Diagnosis of Human Diseases

Dalmasso, A. P. (1986) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368609110272 · Cited by 78 · see citing works

Basal lamina changes in neurodegenerative disorders

Nguyen, B., Bix, G., & Yao, Y. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00502-y · Cited by 75 · see citing works

TDP-43 mediated blood-brain barrier permeability and leukocyte infiltration promote neurodegeneration in a low-grade systemic inflammation mouse model

Zamudio, F., Loon, A. R., Smeltzer, S., Benyamine, K., Shanmugam, N. K. N., Stewart, N. J., Lee, D. C., Nash, K. R., & Selenica, M. B. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01952-9 · Cited by 77 · see citing works

The Complement System in the Central Nervous System: From Neurodevelopment to Neurodegeneration

Chen, Y., Chu, J. M. T., Chang, R. C., & Wong, G. T. C. (2022) · Biomolecules · doi:10.3390/biom12020337 · Cited by 76 · see citing works

Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions

Brennan, F. H., Lee, J. D., Ruitenberg, M. J., & Woodruff, T. M. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.03.015 · Cited by 73 · see citing works

High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients

Annunziata, P., & Volpi, N. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1985.tb01548.x · Cited by 72 · see citing works

Global alterations to the choroid plexus blood-CSF barrier in amyotrophic lateral sclerosis

Saul, J., Hutchins, E. D., Reiman, R. A., Saul, M., Ostrow, L. W., Harris, B. T., Keuren‐Jensen, K. R. V., Bowser, R. P., & Bakkar, N. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00968-9 · Cited by 67 · see citing works

Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: Proposed mechanisms and clinical implications

Steinruecke, M., Lonergan, R. M., Selvaraj, B. T., Chandran, S., Castro, B. D., & Stavrou, M. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231153281 · Cited by 62 · see citing works

Complement Has Brains—Do Intracellular Complement and Immunometabolism Cooperate in Tissue Homeostasis and Behavior?

Kunz, N., & Kemper, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629986 · Cited by 61 · see citing works

Aberrant Complement System Activation in Neurological Disorders

Ziąbska, K., Ziemka‐Nałęcz, M., Pawelec, P., Sypecka, J., & Zalewska, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094675 · Cited by 55 · see citing works

Increased concentration of C4d complement protein in CSF in amyotrophic lateral sclerosis.

Tsuboi, Y., & Yamada, T. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.7.859 · Cited by 54 · see citing works

Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact

Marchi, F. D., Munitić, I., Amedei, A., Berry, J. D., Feldman, E. L., Aronica, E., Nardo, G., Weehaeghe, D. V., Niccolai, E., Prtenjača, N., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.027 · Cited by 52 · see citing works

Altered blood–brain barrier and blood–spinal cord barrier dynamics in amyotrophic lateral sclerosis: Impact on medication efficacy and safety

Pan, Y., & Nicolazzo, J. A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15802 · Cited by 49 · see citing works

Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients

Niebrój-Dobosz, I., Jamrozik, Z., Janik, P., Hausmanowa-Petrusewicz, I., & Kwieciński, H. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb00387.x · Cited by 52 · see citing works

Pharmacological targeting of the PDGF-CC signaling pathway for blood–brain barrier restoration in neurological disorders

Lewandowski, S. A., Fredriksson, L., Lawrence, D. A., & Eriksson, U. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.016 · Cited by 52 · see citing works

Alterations of the blood‐spinal cord barrier in sporadic amyotrophic lateral sclerosis

Sasaki, S. (2015) · Neuropathology · doi:10.1111/neup.12221 · Cited by 49 · see citing works

Revisiting the role of the innate immune complement system in ALS

Parker, S. E., Hanton, A. M., Stefanou, S. N., Noakes, P. G., Woodruff, T. M., & Lee, J. D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.003 · Cited by 50 · see citing works

Serum biomarkers of neuroinflammation and blood-brain barrier leakage in amyotrophic lateral sclerosis

Cao, M. C., Cawston, E. E., Chen, G. L., Brooks, C., Douwes, J. E., McLean, D., Graham, E. S., Dragunow, M., & Scotter, E. L. (2022) · BMC Neurology · doi:10.1186/s12883-022-02730-1 · Cited by 47 · see citing works

Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS

Waters, S., Dieriks, B. V., Swanson, M. E. V., Zhang, Y., Grimsey, N. L., Murray, H. C., Turner, C. P., Waldvogel, H. J., Faull, R. L. M., An, J., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01244-0 · Cited by 48 · see citing works

Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis

Bowerman, M., Vincent, T., Scamps, F., Perrin, F. E., Camu, W., & Raoul, C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00214 · Cited by 46 · see citing works

Microvascular disturbance with decreased pericyte coverage is prominent in the ventral horn of patients with amyotrophic lateral sclerosis

Yamadera, M., Fujimura, H., Inoue, K., Toyooka, K., Mori, C., Hirano, H., & Sakoda, S. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1011663 · Cited by 49 · see citing works

Glycans in Sera of Amyotrophic Lateral Sclerosis Patients and Their Role in Killing Neuronal Cells

Edri‐Brami, M., Rosental, B., Hayoun, D., Welt, M., Rosen, H., Wirguin, I., Nefussy, B., Drory, V. E., Porgador, A., & Lichtenstein, R. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035772 · Cited by 45 · see citing works

Complement in Neurologic Disease

Propson, N. E., Gedam, M., & Zheng, H. (2020) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-031620-113409 · Cited by 43 · see citing works

A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis.

Stevens, A., Weller, M., & Wiethölter, H. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.4.361 · Cited by 43 · see citing works

Neurovascular Aspects of Amyotrophic Lateral Sclerosis

Oliveira, M. C., Hernandez‐Ontiveros, D. G., Louis, M. K., Willing, A. E., Borlongan, C. V., Sanberg, P. R., Voltarelli, J. C., & Garbuzova-Davis, S. N. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00004-1 · Cited by 42 · see citing works

Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression

Saleh, I. A., Zesiewicz, T., Xie, Y., Sullivan, K. L., Miller, A. M., Kuzmin‐Nichols, N., Sanberg, P. R., & Garbuzova-Davis, S. N. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.07.011 · Cited by 36 · see citing works

Blood–Brain Barrier Driven Pharmacoresistance in Amyotrophic Lateral Sclerosis and Challenges for Effective Drug Therapies

Mohamed, L. A., Markandaiah, S. S., Bonanno, S., Pasinelli, P., & Trotti, D. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0120-6 · Cited by 35 · see citing works

Motor neuron diseases and amyotrophic lateral sclerosis: research progress

Rowland, L. P. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90004-x · Cited by 34 · see citing works

MOLECULAR APPROACHES TO AMYOTROPHIC LATERAL SCLEROSIS

Smith, R. G., & Appel, S. H. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.133 · Cited by 32 · see citing works

Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics

Gavriilaki, M., Kimiskidis, V. Κ., & Gavriilaki, E. (2020) · Pharmaceuticals · doi:10.3390/ph13110341 · Cited by 31 · see citing works

Role of Complement in Motor Neuron Disease: Animal Models and Therapeutic Potential of Complement Inhibitors

Woodruff, T. M., Costantini, K. J., Taylor, S. M., & Noakes, P. G. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78952-1_11 · Cited by 30 · see citing works

Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis

van Blitterswijk, M., Gulati, S., Smoot, E. W., Jaffa, M., Maher, N. E., Hyman, B. T., Ivinson, A. J., Scherzer, C. R., Schoenfeld, D., Cudkowicz, M., et al. (2011) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.585163 · Cited by 31 · see citing works

TDP-43 Vasculopathy in the Spinal Cord in Sporadic Amyotrophic Lateral Sclerosis (sALS) and Frontal Cortex in sALS/FTLD-TDP

Ferrer, I., Andrés‐Benito, P., Carmona, M., Assialioui, A., & Povedano, M. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa162 · Cited by 29 · see citing works

Brain Vascular Health in ALS Is Mediated through Motor Cortex Microvascular Integrity

Schreiber, S., Bernal, J., Arndt, P., Schreiber, F., Müller, P., Morton, L., Braun-Dullaeus, R. C., Hernández, M. D. C. V., Duarte, R., Wardlaw, J. M., et al. (2023) · Cells · doi:10.3390/cells12060957 · Cited by 27 · see citing works

Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis

Faller, K. M. E., Chaytow, H., & Gillingwater, T. H. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-024-01049-4 · Cited by 28 · see citing works

Expression of the ALS-Causing Variant hSOD1 G93A Leads to an Impaired Integrity and Altered Regulation of Claudin-5 Expression in an in Vitro Blood–Spinal Cord Barrier Model

Meister, S., Storck, S. E., Hameister, E., Behl, C., Weggen, S., Clement, A. M., & Pietrzik, C. U. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.57 · Cited by 27 · see citing works

Internalization of plasma proteins by cerebellar Purkinje cells

Fishman, P. S., Farrand, D. A., & Kristt, D. A. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90011-b · Cited by 27 · see citing works

Reduction of microhemorrhages in the spinal cord of symptomatic ALS mice after intravenous human bone marrow stem cell transplantation accompanies repair of the blood-spinal cord barrier

Eve, D. J., Steiner, G. A., Mahendrasah, A., Sanberg, P. R., Kurien, C., Thomson, A., Borlongan, C. V., & Garbuzova-Davis, S. N. (2018) · Oncotarget · doi:10.18632/oncotarget.24360 · Cited by 26 · see citing works

Brain–body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis

Jacob, S. M., Lee, S., Kim, S. H., Sharkey, K. A., Pfeffer, G., & Nguyen, M. D. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00991-7 · Cited by 25 · see citing works

C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis

Lai, J. D., & Ichida, J. K. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134523 · Cited by 23 · see citing works

Peripheral nerve atrophy together with higher cerebrospinal fluid progranulin indicate axonal damage in amyotrophic lateral sclerosis

Schreiber, S., Dębska–Vielhaber, G., Abdulla, S., Machts, J., Schreiber, F., Kropf, S., Körtvélyessy, P., Körner, S., Kollewe, K., Petri, S., et al. (2017) · Muscle & Nerve · doi:10.1002/mus.25682 · Cited by 22 · see citing works

Experimental immune-mediated motor neuron diseases: Models for human ALS

SMITH, R. G., Engelhardt, J. I., Tajti, J., & Appel, S. H. (1993) · Brain Research Bulletin · doi:10.1016/0361-9230(93)90268-g · Cited by 22 · see citing works

Low-intensity pulsed ultrasound modulates disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis

Liu, Z., Zhang, H., Lu, K., Chen, L., Zhang, Y., Xu, Z., Zhou, H., Sun, J., Xu, M., Ouyang, Q., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114660 · Cited by 20 · see citing works

Amyotrophic lateral sclerosis associated with IgG anti-GalNAc-GD1a antibodies

Yamazaki, T., Suzuki, M., Irie, T., Watanabe, T., Mikami, H., & Ono, S. (2008) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2008.03.010 · Cited by 19 · see citing works

Immunocomplexes in rat and rabbit spinal cord after injury

Palladini, G., Grossi, M., Maleci, A., Lauro, G. M., & Guidetti, B. (1987) · Experimental Neurology · doi:10.1016/0014-4886(87)90305-0 · Cited by 18 · see citing works

ALS-causing SOD1 mutants regulate occludin phosphorylation/ubiquitination and endocytic trafficking via the ITCH/Eps15/Rab5 axis

Tang, J., Kang, Y., Zhou, Y., Li, X., Lan, J., Wu, L., Feng, X., & Peng, Y. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105315 · Cited by 16 · see citing works

Immunology of amyotrophic lateral sclerosis

Cashman, N. R., Gurney, M., & Antel, J. P. (1985) · Springer Seminars in Immunopathology · doi:10.1007/bf00197252 · Cited by 17 · see citing works

Restoring brain barriers: an innovative approach for treating neurological disorders

Lemarchant, S., Engelhardt, B., Cicchetti, F., Bix, G. J., Janus, A., Godfrin, Y., Blasco, H., Campbell, M., & Jacquet, A. D. R. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00688-z · Cited by 16 · see citing works

Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies

Reyes‐Leiva, D., Dols‐Icardo, O., Sirisi, S., Cortés‐Vicente, E., Turón‐Sans, J., de Luna, N., Blesa, R., Belbin, O., Montal, V., Alcolea, D. A., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.750543 · Cited by 15 · see citing works

Taking Advantages of Blood–Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS?

Alarcan, H., Ojaimi, Y. A., Lanznaster, D., Escoffre, J., Corcia, P., Vourc’h, P., Andres, C. R., Veyrat‐Durebex, C., & Blasco, H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12071071 · Cited by 16 · see citing works

Neurovascular dynamics in the spinal cord from development to pathophysiology

de Almodóvar, C. R., Dupraz, S., & Bonanomi, D. (2025) · Neuron · doi:10.1016/j.neuron.2025.09.017 · Cited by 15 · see citing works

Integrated transcriptomic profiling reveals a STING-mediated Type II Interferon signature in SOD1-mutant amyotrophic lateral sclerosis models

Hiew, J. Y., Lim, Y.-B., Liu, H., & Ng, C. S. (2025) · Communications Biology · doi:10.1038/s42003-025-07790-w · Cited by 16 · see citing works

Humoral response to neurofilaments and dipeptide repeats in ALS progression

Puentes, F., Lombardi, V., Lu, C., Yildiz, Ö., Fratta, P., Isaacs, A. M., Bobeva, Y., Wuu, J., Benatar, M. G., & Malaspina, A. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51428 · Cited by 14 · see citing works

Association of polyclonal anti-GM1 IgM and anti-neurofilament antibodies with CSF oligoclonal bands in a young with amyotrophic lateral sclerosis

Annunziata, P., Maimone, D., & Guazzi, G. C. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1995.tb00152.x · Cited by 14 · see citing works

Penetration and internalization of plasma proteins in the human spinal cord

Fishman, P. S., Farrand, D. A., & Kristt, D. A. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90306-r · Cited by 14 · see citing works

The case for complement component 5 as a target in neurodegenerative disease

Stennett, A., Friston, K., Harris, C. L., Wollman, A. J. M., Bronowska, A. K., & Madden, K. S. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2177532 · Cited by 12 · see citing works

Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells—Focus on Immunological Pathways in Patients with ALS

Baumert, B., Sobuś, A., Gołąb-Janowska, M., Paczkowska, E., Łuczkowska, K., Rogińska, D., Zawiślak, A., Milczarek, S., Osękowska, B., Pawlukowska, W., et al. (2020) · Cells · doi:10.3390/cells9081822 · Cited by 12 · see citing works

Ascorbate availability and neurodegeneration in amyotrophic lateral sclerosis

Kok, A. (1997) · Medical Hypotheses · doi:10.1016/s0306-9877(97)90097-9 · Cited by 12 · see citing works

Immunoregulatory and activated T cells in amyotrophic lateral sclerosis patients

Bartfeld, H., Dham, C., & Donnenfeld, H. (1985) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(85)80013-8 · Cited by 12 · see citing works

Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial

Perrin, S., Ladha, S. S., Maragakis, N. J., Rivner, M. H., Katz, J., Genge, A. L., Olney, N. T., Lange, D. J., Heitzman, D., Bodkin, C. L., et al. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004469 · Cited by 11 · see citing works

Interfering with lysophosphatidic acid receptor edg2/lpa 1 signalling slows down disease progression in SOD1‐G93A transgenic mice

Gento‐Caro, Á., Vilches‐Herrando, E., García‐Morales, V., Portillo, F., Bey, G. R., González‐Forero, D., & Moreno‐López, B. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12699 · Cited by 11 · see citing works

The Role of Pericytes in Amyotrophic Lateral Sclerosis

Coatti, G. C., Cavaçana, N., & Zatz, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-16908-4_6 · Cited by 10 · see citing works

Decreased blood CD4+ T lymphocyte helps predict cognitive impairment in patients with amyotrophic lateral sclerosis

Yang, Y., Pan, D., Gong, Z., Tang, J., Li, Z., Ding, F., Liu, M., & Zhang, M. (2021) · BMC Neurology · doi:10.1186/s12883-021-02185-w · Cited by 10 · see citing works

Innate Immunity in ALS

John, D., Yuehui, J., Stephen, M., Noakes, P. G., & Woodruff, T. M. (2012) · InTech eBooks · doi:10.5772/30341 · Cited by 10 · see citing works

Pathophysiology of the choroid plexus in brain diseases

Mihaljević, S., Michalicová, A., Bhide, M., & Kováč, A. (2021) · General Physiology and Biophysics · doi:10.4149/gpb_2021032 · Cited by 9 · see citing works

Theories of Causation

Appel, S. H., Engelhardt, J. I., Smith, R. G., & Stefani, E. (1995) · Springer eBooks · doi:10.1007/978-1-4471-1871-8_11 · Cited by 9 · see citing works

Metabolic Reprogramming in Nerve Cells

Bhattacharya, S. (2023) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2023.18.002444 · Cited by 8 · see citing works

Autoimmunity and ALS: studies on antibodies to acetylcholinesterase in sera

Häggström, B., Andersen, P. M., Hjalmarsson, K., Binzer, M., & Forsgren, L. (1997) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1997.tb00079.x · Cited by 7 · see citing works

Patching Up the Permeability: The Role of Stem Cells in Lessening Neurovascular Damage in Amyotrophic Lateral Sclerosis

Monsour, M., Garbuzova-Davis, S. N., & Borlongan, C. V. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac072 · Cited by 6 · see citing works

Disruption of blood-brain barrier in amyotrophic lateral sclerosis: an update

Brylev, L., Zakharova, M. N., Завалишин, И. А., & Gulyaeva, N. V. (2012) · Neurochemical Journal · doi:10.1134/s1819712411040064 · Cited by 5 · see citing works

The Neuroinflammation in the Physiopathology of Amyotrophic Lateral Sclerosis

Bowerman, M., Vincent, T., Scamps, F., Camu, W., & Raoul, C. (2013) · InTech eBooks · doi:10.5772/56489 · Cited by 5 · see citing works

IgG Reactivity in the Spinal Cord and Motor Cortex in Amyotrophic Lateral Sclerosis

Engelhardt, J. I., & Appel, S. H. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530110068019 · Cited by 221 · see citing works

Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.

Kawamata, T., Akiyama, H., Yamada, T., & McGeer, P. L. (1992) · PubMed Central · Cited by 546 · see citing works

Subcellular localization of IgG from the sera of ALS patients in the nervous system

Engelhardt, J. I., Soós, J., Obál, I., Vigh, L., & Siklós, L. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00445.x · Cited by 38 · see citing works

Serum and CSF immunological findings in ALS

Apostolski, S., Nikolić, J., Bugarski-Prokopljević, C., Miletić, V., Pavlović, S., & Filipović, S. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb04656.x · Cited by 114 · see citing works

Evaluation of Peripheral Immune Activation in Amyotrophic Lateral Sclerosis

Wang, M., Liu, Z., Du, J., Yuan, Y., Jiao, B., Zhang, X., Hou, X., Shen, L. H., Guo, J., Jiang, H. F., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.628710 · Cited by 7 · see citing works